Determination of the Relationship of Serum Hyaluronic Acid Levels to the Degree of Liver Fibrosis in Biopsies of Patients with Chronic Viral Hepatitis B & C
Authors:
Moradi Moghaddam F
Department of Internal Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
Arrbabi H
Department of Internal Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
Khajedaloei M
Department of Public Medicine, Ghaem Hospital, Mashad University of Medical Sciences, Mashhad, Iran
Correspondence:
Hossein Arrbabi, M.D.
Department: Department of Internal Medicine, Ghaem Hospital, Mashhad University of Medical Sciences
City: Mashhad
Country: Iran
E-mail: HF_sina@yahoo.com
Tel: +98 511 840 0000
Fax: +98 511 840 0000
References:
1. Zheng M, Cai WM, Weng HL, Liu RH. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J Gastroenterol. 2002;8(6):1073-6. [PubMed]
2. Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc. 2007;82(8):967-75. [PubMed]
3. Khan JA, Khan FA, Dilawar M, Ijaz A, Khan NA, Mehmood T. Serum hyaluronic acid as a marker of hepatic fibrosis. J Coll Physicians Surg Pak. 2007;17(6):323-6. [PubMed]
4. Yilmaz S, Bayan K, Tuzun Y, et al. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. Int J Clin Pract. 2007;61(3):438-43. [PubMed]
5. Lu LG, Zeng MD, Wan MB, et al. Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters. World J Gastroenterol. 2003;9(11):2574-8. [PubMed]
6. Montazeri G, Estakhri A, Mohamadnejad M, et al. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol. 2005;5:32. [PubMed]
7. Halfon P, Bourliere M, Penaranda G, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol. 2005;4:6. [PubMed]
8. Lebensztejn DM, Skiba E, Tobolczyk J, Sobaniec-Lotowska ME, Kaczmarski M. Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis. World J Gastroenterol. 2005;11(45):7192-6. [PubMed]
9. Skripenova S, Trainer TD, Krawitt EL, Blaszyk H. Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. J Clin Pathol. 2007;60(3):321-4. [PubMed]
10. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97(10):2614-8. [PubMed]
11. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39(2):239-44. [PubMed]
12. Guechot J, Serfaty L, Bonnand AM, Chazouilleres O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol. 2000;32(3):447-52. [PubMed]
13. Vrochides D, Papanikolaou V, Pertoft H, Antoniades AA, Heldin P. Biosynthesis and degradation of hyaluronan by nonparenchymal liver cells during liver regeneration. Hepatology. 1996;23(6):1650-5. [PubMed]
14. Hartley JL, Brown RM, Tybulewicz A, et al. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease. J Pediatr Gastroenterol Nutr. 2006;43(2):217-21. [PubMed]
15. Kim MY, Baik SK, Jang YO, et al. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model]. Korean J Hepatol. 2008;14(2):159-67. [PubMed]
16. Ding H, Chen Y, Feng X, Liu D, Wu A, Zhang L. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. 2001;9(2):78-80. [PubMed]
17. Wyatt HA, Dhawan A, Cheeseman P, Mieli-Vergani G, Price JF. Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease. Arch Dis Child. 2002;86(3):190-3. [PubMed]
18. Fried MW, Duncan A, Soroka S, et al. Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation. Bone Marrow Transplant. 2001;27(6):635-9. [PubMed]
19. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat. 1998;5(3):187-92. [PubMed]
20. Curry M, Afdhal H. Serum markers of hepatic fibrosis. UpToDate; 2005.
21. Nyberg A, Engstrom-Laurent A, Loof L. Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage. Hepatology. 1988;8(1):142-6. [PubMed]